Jacques Morel

Treatment of Primary Sjögren Syndrome With Rituximab

Valérie Devauchelle‐Pensec, Xavier Mariette, Sandrine Jousse‐Joulin et al. · Annals of Internal Medicine · 2014 · 436 citations

Life Sciences, Clinical Sciences, Immunology +17

Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome

Jacques‐Eric Gottenberg, Philippe Ravaud, Xavier Puéchal et al. · JAMA · 2014 · 300 citations

Medicine, Internal Medicine, Pharmacotherapy +16

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

Cem Gabay, Bruno Fautrel, Jürgen Rech et al. · Annals of the Rheumatic Diseases · 2018 · 291 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Dominique Salmon‐Céron, Florence Tubach, Olivier Lortholary et al. · Annals of the Rheumatic Diseases · 2010 · 283 citations

Medicine, Immunology, Pharmacotherapy +11